Submodule
The Enteral Decision
Use the gastrointestinal tract when it can safely receive and absorb nutrients, but separate a functioning gut from a patient who is not yet adequately resuscitated.
- Indications and goals
- Hemodynamic stability
- Contraindications
- Early critical care feeding
Oral intake cannot safely meet the target
Digestion and absorption are usable
Resuscitation is complete and stable
Choose oral, gastric, or postpyloric delivery
Prefer the gut when it is usable
Enteral nutrition delivers nutrients through the gastrointestinal tract by mouth or feeding tube. It supports gut structure and function, avoids central venous access, and is generally preferred to parenteral nutrition when digestion and absorption are adequate. It does not replace an oral diet when safe oral intake can meet the patient's needs.
Recognize the patient who needs support
Consider enteral nutrition when oral intake is unsafe, impossible, or persistently inadequate. Common settings include dysphagia, neurologic injury, mechanical obstruction above a functioning gut, critical illness, cancer treatment, and increased requirements that cannot be met orally. Nutrition risk and expected duration matter more than a single day count.
Do not feed through active instability
Bowel ischemia, obstruction, uncontrolled gastrointestinal bleeding, and anatomy that prevents safe access can preclude enteral feeding. During uncontrolled shock or escalating vasopressor support, stabilize perfusion before advancing nutrition. Once resuscitation is complete and the patient is stable, carefully monitored low-dose feeding may be appropriate.
Use early feeding with clinical judgment
ASPEN guidance supports early enteral nutrition for critically ill adults who cannot maintain oral intake, usually within 24 to 48 hours when hemodynamically stable. Timing, dose, and advancement must account for perfusion, gastrointestinal tolerance, nutrition risk, refeeding risk, and the possibility that a procedure or changing condition will interrupt delivery.
Quick check
Submodule
Access and Route Selection
Access is chosen by expected duration, anatomy, gastric emptying, aspiration risk, procedural burden, and the therapies that must pass through the tube.
- Gastric versus postpyloric
- Nasal versus percutaneous
- Placement confirmation
- ENFit safety
Gastric or postpyloric
Bolus, intermittent, continuous
Controlled small bowel delivery
Gastrostomy or jejunostomy
Start with the stomach when appropriate
Gastric access is physiologic, accommodates larger volumes, and supports bolus, intermittent, or continuous delivery. Nasogastric access is useful for shorter courses, while gastrostomy is considered when longer support is expected. Reflux, impaired gastric emptying, aspiration risk, facial injury, and anatomy can change the choice.
Move beyond the pylorus for a reason
Duodenal or jejunal delivery may help when gastric feeding is not tolerated, the gastric outlet is obstructed, or aspiration risk remains high despite preventive measures. Small bowel access usually requires continuous pump delivery because the intestine lacks the stomach's reservoir capacity. Medication delivery may also be limited by absorption site and tube diameter.
Confirm before first use
A blindly placed feeding tube must be confirmed using an evidence-based method before initial feeding or medication administration. Radiographic confirmation is the reference standard for many newly placed small-bore tubes. Air auscultation alone is not reliable. Reassess external length, securement, and clinical signs when migration is possible.
Prevent wrong-route connections
Enteral-specific connectors such as ENFit are designed to reduce dangerous connections between enteral and intravenous systems. Trace every line from patient to source, label enteral equipment, use enteral syringes, and never force incompatible connectors. A connection that is physically possible is not automatically clinically correct.
Quick check
Submodule
Delivery and the Feeding Prescription
The prescription links a daily nutrient and fluid target to a formula, route, rate, schedule, flush plan, and advancement strategy.
- Bolus, intermittent, and continuous delivery
- Daily volume targets
- Rate calculations
- Advancement and interruptions
What must reach the patient
Volume divided by running hours
Continuous, cyclic, intermittent, bolus
Account for every interruption
Match method to access and tolerance
Bolus feeding resembles meals and can support mobility and home routines, but it is generally limited to gastric access and lower aspiration risk. Intermittent delivery extends each feeding over a longer period. Continuous pump delivery is useful for small bowel access, critical illness, poor tolerance, high refeeding risk, or when slower delivery improves control.
Prescribe the full system
Name the product, access site, method, goal rate or volume, schedule, advancement, water flushes, and monitoring. A rate without a duration does not define daily delivery. For example, 60 mL per hour for 20 hours provides 1,200 mL, not the 1,440 mL that would be delivered over 24 hours.
Advance according to risk
Advancement is individualized. A stable patient with an established tube may progress differently from a patient with shock recovery, refeeding risk, severe electrolyte depletion, or new postpyloric access. Monitor symptoms, abdominal findings, stool pattern, glucose, fluid status, and electrolytes instead of escalating by clock alone.
Manage interruptions deliberately
Procedures, imaging, medication administration, tube problems, and nursing care can reduce delivered nutrition. Avoid unnecessary holds. Volume-based protocols can compensate for predictable interruptions in appropriate patients, but the revised rate must remain safe for the route, formula, and clinical condition.
Quick check
Submodule
Formula Selection and Hydration
Choose the least complex formula that meets nutrient, volume, digestion, absorption, electrolyte, and tolerance needs.
- Polymeric and peptide-based formulas
- Caloric density
- Fiber and disease-specific products
- Free water and renal solute load
Use when digestion and absorption work
Use for a defined absorption problem
Trade volume for free water
Formula plus flushes plus other intake
Use standard formulas when digestion works
Polymeric formulas contain intact protein, carbohydrate, and fat and are appropriate for many patients with adequate digestion and absorption. Peptide-based formulas use hydrolyzed protein and modified fat, while elemental formulas provide free amino acids. Greater nutrient hydrolysis does not automatically improve outcomes and should answer a defined malabsorption or intolerance problem.
Use density to solve a volume problem
Higher caloric density delivers more energy in less formula volume but usually provides less free water per calorie and may increase viscosity or renal solute load. A fluid-restricted patient may benefit, while a dehydrated patient can worsen if flushes are not adjusted. Calculate formula water from product data rather than assuming formula volume equals water.
Treat fiber and specialty claims carefully
Soluble and mixed fibers may support bowel function in selected stable patients. Avoid routine insoluble fiber when bowel perfusion or motility is impaired. Renal, pulmonary, diabetes, immune-modulating, and other specialty formulas differ in composition, but the disease label alone does not prove that a product is required.
Build the water prescription
Total water includes formula free water, medication flushes, scheduled tube flushes, oral intake, and intravenous fluid. Subtract known sources from the individualized daily target to estimate supplemental water. Then adjust for fever, losses, organ function, sodium status, and the safety of the selected access route.
Quick check
Submodule
Medication Administration Through Enteral Access
Safe medication delivery requires a dosage-form review, absorption-site review, drug-specific feeding plan, and flush sequence for every administration.
- Do-not-crush formulations
- Drug and nutrient interactions
- Flush sequence
- Tube site and dosage form
Crushability, release, hazard
Gastric conditions and absorption site
Never mix into formula
Protect dose and tube patency
Review the dosage form before altering it
Do not crush extended-release, delayed-release, enteric-coated, sublingual, buccal, or hazardous products unless a trusted drug-specific source explicitly permits an alternative technique. Immediate-release tablets may be crushable, and some capsules may be opened, but each product must be checked. Select a compatible liquid or alternative route when possible.
Separate medications from formula and each other
Stop feeding only when the drug or clinical situation requires it. Flush the tube, administer each medication separately, flush between medications, and flush after the final dose before restarting feeding. Do not mix medications directly into formula or combine several medications in one syringe. Use an enteral syringe and water appropriate to the patient and route.
Manage interactions by mechanism
Calcium and other cations can reduce absorption of selected fluoroquinolones and tetracyclines. Enteral nutrition can reduce phenytoin and levothyroxine exposure, while formula vitamin K content can affect warfarin response. The correct hold interval is drug specific. Monitor the clinical endpoint or concentration when available instead of applying a universal two-hour hold to every medication.
Respect the tube tip
A medication that requires gastric acid, gastric activation, or absorption in the proximal intestine may not work when delivered into the jejunum. Hyperosmolar liquids and sorbitol-containing products can worsen diarrhea. Confirm compatibility, dilute when appropriate, account for flush volume, and document the access site in medication reconciliation.
Quick check
Submodule
Monitoring and Complication Prevention
Tolerance is a clinical pattern. Integrate delivered volume, symptoms, examination, stool, fluid balance, glucose, electrolytes, access integrity, and infection risk.
- Aspiration prevention
- Diarrhea and intolerance
- Tube obstruction and displacement
- Refeeding and metabolic monitoring
Assess rate, disease, infection, drugs
Watch refeeding and hydration
Migration, clogging, leakage
Audit holds, pump, preparation
Prevent aspiration with a bundle
Elevate the head of the bed 30 to 45 degrees when clinically feasible, verify tube position, reduce unnecessary sedation, assess gastric emptying, and consider postpyloric access for persistent high-risk cases. Blue dye or methylene blue should not be added to formula. A single gastric residual volume is not a diagnosis of intolerance.
Use gastric residuals selectively
Current critical care guidance does not support routine gastric residual volume monitoring in every patient. When a unit uses residuals, do not automatically stop feeding for a value below 500 mL in the absence of other intolerance signs. Interpret trends with vomiting, distention, pain, hemodynamics, stool, imaging, and aspiration risk.
Find the cause of diarrhea and clogging
Antibiotics, sorbitol, laxatives, infection, rapid delivery, and underlying disease often explain diarrhea better than formula osmolality alone. For a clogged tube, check for kinks and use warm water with gentle pressure as the first approach. Avoid acidic beverages, forceful pressure, and improvised objects. Enzyme-based declogging follows protocol.
Monitor delivery and metabolic safety
Track actual volume, weight trend, intake and output, glucose, sodium, potassium, magnesium, phosphate, kidney function, and signs of dehydration or overload at an acuity-matched interval. Patients at refeeding risk need correction and close monitoring of phosphate, potassium, and magnesium during cautious initiation. Review formula preparation, hang time, hand hygiene, and the insertion site to prevent contamination and infection.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.
- ASPEN Safe Practices for Enteral Nutrition Therapy
- ASPEN guideline for nutrition support in the adult critically ill patient
- SCCM and ASPEN adult critical care nutrition guideline
- ASPEN consensus recommendations for refeeding syndrome
- FDA guidance on enteral connector misconnections
- FDA medical device connector safety resources